Hot Features
Premium
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
LB Foster Co. (NASDAQ:FSTR): The stock zoomed past its previous 52 weeks high of $42.25 and touched $42.51. Its lowest price point for the session stood at $42. LB Foster is currently trading at $42.30, up 0.33 percent from its previous close of $42.16.
The stock is buoyant on the news of its new concrete tie contract with Union Pacific. This multiyear contract pertains to prestressed concrete railroad, however, the companies did not disclose the financial terms. The stock is trading at the Price Earnings ratio of 27.54 and has traded in the range of $24.94 and $42.51 in the past 52 weeks. LB Foster is trading above its 20 days moving average price of $42.28 and 50 days moving average price of $42.20. The company was formed in 1902 and it is based out of Pennsylvania. LB Foster deals in fabrication and manufacturing of services for various industries including energy and rail.
Intercept Pharmaceuticals Inc. (NASDAQ:ICPT): The stock is currently trading at $34.45, up 4.39 percent from its previous close of $33.00. It touched its new 52 weeks high of $34.48, upping the previous high of $33.13. The company is a development stage biopharmaceutical outfit. It is currently working on a drug candidate codenamed INT-767 for treating fibrosis while its another drug candidate INT-777 for treating type 2 diabetes. Intercept Pharmaceuticals stock’s lowest price point for the session stands at $32.97. It has traded in the range of $17.96 and $34.48 in the past 52 weeks. Intercept Pharmaceuticals is based out of New York and was formed in 2002. The company operates as a subsidiary of Genextra. The stock is trading above its 20 days moving average price of $34.22 and 50 days moving average price of $33.28.
GeoEye Inc. (NASDAQ:GEOY): The company is looking to expand its operations in Middle East and opened a new office in Abu Dhabi for this purpose. GeoEye also recently combined itself with DigitalGlobe after received 98.3 percent approval from its shareholders. The company stock traded in the range of $31.20 and $32.76 in the current trading session and is currently at $32.44, up 2.04 percent from its previous close of $31.79. GeoEye reported the termination of its OTFPP agreement with NGA. The agreement was entered into through its subsidiary GeoEye Imagery Collection Systems. However, the stock is trading above its 20 days moving average price of $32.43 and 50 days moving average price of $32.27. The stock is trading at the Price Earnings ratio of 15.84. GeoEye offers geospatial information and data. The company also owns earth imaging satellites. It is based out of Herndon in Virginia.
Financial Engines Inc. (NASDAQ:FNGN): The stock is currently trading at $27.82, up 1.53 percent from its previous close of $27.40. It set a new 52 weeks high of $28.09 in the current trading session. The stock’s previous 52 weeks high stood at $27.83. The stock is trading at the Price Earnings ratio of 77.22. Financial Engines recently announced the appointment of Paul Gamble as its new Executive Vice President. The company offers technology enabled investment services and management advice. Financial Engines is based out of Palo Alto and was formed in 1996. The company also provides professional management services aimed at customers looking for personalized portfolio management advice. The stock has traded in the range of $18.10 and $28.09 in the past 52 weeks. However, the stock is trading below its 20 days moving average price of $27.84 and 50 days moving average price of $27.88.
Infinity Pharmaceuticals Inc. (NASDAQ:INFI): The stock is sharply up on the news of the pricing of its public offering. Infinity Pharmaceuticals announced that its 5.7 million shares offering will be priced at $26.33 per share. The company also reported the results of its Phase 1trial of its drug candidate IPI-145 for treating advanced hematologic malignancies. The stock is currently trading at $28.19, up 7.06 percent from its previous close of $26.33. The stock is trading at the beta of 0.82. The company reported its latest EPS at -$0.75 per share. Infinity Pharmaceuticals is trading below its 20 days moving average price of $28.20 and 50 days moving average price of $28.34. The company is engaged in the business of developing therapies for various ailments. Infinity Pharmaceuticals is based out of Massachusetts.
